FH and renal cell carcinoma: Chen et al. reported a study of an uncharacterized RCC cohort, in which FH-deficient patients with stage III RCC(n = 4) displayed the worst progression-free survival (PFS) and overall survival (OS), and all died within 40 months of their diagnosis (9).